Dr. Heidi Snethen

Heidi started her research career in the multiple sclerosis and stem cell group, University of Bristol, and received her PhD in Neuroscience from the University of Bristol in 2012. Since then, she has been involved in projects identifying maternal microchimera cells in the human brain, assessing the potential of mesenchymal stem cells as a therapy for multiple sclerosis and most recently testing novel therapeutic targets for focal segmental glomerulosis kidney disease. Heidi joined the Armstrong Group in January 2024 to support soft robotics and organoid engineering projects.